Search

Minimally invasive surgery (MIS) to resect liver segments 7 and 8 is safe for select patients treated by experienced MIS hepatopancreatobiliary surgeons.

… Tuesday, March 2, 2021 Minimally invasive surgery (MIS) to resect liver segments 7 and 8 is safe for select patients treated by experienced MIS hepatopancreatobiliary surgeons, according to our retrospective study published recently in the Journal of Surgical Oncology .  (1) Whether MIS is a safe and

Researchers have discovered that cancer cells may hijack an immune response to spread from a primary tumor to distant organs.

… Wednesday, January 17, 2018 Summary A new finding suggests that a genetic mistake in cancer cells known as chromosomal instability creates an inflammatory state within the cells. The cancer cells take advantage of this condition by hijacking pathways used by immune cells to migrate. This enables these

Michael A. Foley, PhD, has been selected to lead the Tri-Institutional Therapeutics Discovery Institute, Inc., a pioneering collaboration of Weill Cornell Medical College, The Rockefeller University and Memorial Sloan Kettering Cancer Center.

… Thursday, December 5, 2013 Michael A. Foley, PhD, has been selected to lead the Tri-Institutional Therapeutics Discovery Institute , Inc. (Tri-I TDI), a pioneering collaboration of Weill Cornell Medical College, The Rockefeller University and Memorial Sloan Kettering Cancer Center that is designed to

The FDA has approved the first-ever treatment developed for low-grade serous ovarian cancer, a rare type of ovarian cancer.

… Monday, May 12, 2025 The first drug for a rare and difficult-to-treat type of  ovarian cancer has been granted  accelerated approval by the Food and Drug Administration (FDA). The treatment, called avutometinib plus defactinib (Avmapki TM Fakzynja TM Co-pack), was developed to treat low-grade serous

MSK President and CEO, Craig B. Thompson, MD, has been named a founding member of the New York Jobs CEO Council. Dr. Thompson joins CEOs from 27 of the largest employers in New York in the new CEO-led, action-oriented coalition.

… Tuesday, August 11, 2020 Memorial Sloan Kettering President and CEO, Craig B. Thompson, MD , has been named a founding member of the New York Jobs CEO Council. Dr. Thompson joins CEOs from 27 of the largest employers in New York in the new CEO-led, action-oriented coalition. The council will collaborate

Scientists are dusting off their biochemistry textbooks in the hunt for clues to cancer.

… Wednesday, November 23, 2016 Summary Prompted by MSK President and CEO Craig Thompson , cancer researchers are returning to the topic of metabolism for answers about what makes cancer cells go haywire. Highlights Metabolism refers to how cells acquire nutrients and energy. The products of metabolism

Cell biologist Michael Overholtzer will succeed DNA replication expert Ken Marians.

… Friday, October 19, 2018 Call it a changing of the guard. Come January 1, 2019, the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) — MSK’s PhD-granting institution — will have a new dean. GSK’s Board of Trustees voted yesterday to appoint cell biologist Michael Overholtzer to this

Seven students have successfully defended their dissertations and will receive their PhD degrees at commencement on May 18.

… Tuesday, May 16, 2017 Summary Seven students will receive their doctorate degrees this week from the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences at Memorial Sloan Kettering. This innovative program prepares the next generation of basic laboratory scientists to work in research areas

Learn more about a new radiopharmaceutical treatment for prostate cancer approved by the FDA for more patients.

… Tuesday, May 20, 2025 President Joseph Biden is one of an https://pmc.ncbi.nlm.nih.gov/articles/PMC10159917/ estimated 120,000 men  living with stage 4 https://www.mskcc.org/cancer-care/types/prostate prostate cancer .  Fortunately, there are effective treatments that can slow or stop prostate cancer

Eric Alonzo successfully defended his thesis in September 2011. He completed his dissertation research in the laboratory of Dr. Derek Sant'Angelo in the Immunology Program.

… Saturday, October 15, 2011 About Eric Alonzo’s Dissertation Research Eric completed his dissertation research in the laboratory of Dr. Derek Sant’Angelo in the Immunology Program. Broadly, the Sant’Angelo lab is focused on the factors that control lymphocyte development. Specifically, Dr. Sant’Angelo